Clinical Application Value of Deep Learning-Based "Opportunistic Screening" for Malignant Tumors on Routine Non-Contrast Chest-Abdomen-Pelvis CT

ConditionTumor
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorLian Yang

About this trial

This study aims to develop and validate a deep learning-based opportunistic multi-cancer screening system using routine non-contrast chest-abdomen-pelvis CT examinations, including CHANCE-Breast, CHANCE-Liver, CHANCE-Kidney, and CHANCE-Bladder, for the early detection of breast, liver, kidney, and bladder cancers. In addition, the study will assess a human-AI collaborative framework to determine its potential for improving cancer detection and reducing missed diagnoses in clinical practice.

Eligibility criteria

Qualifiers

Patients with a confirmed diagnosis of the target malignancy who received treatment at our institution;

Diagnostic-quality CT images without substantial metal or motion artifacts and with complete anatomical coverage of the target organ (breast, liver, kidney, or bladder);

Availability of complete pre-treatment non-contrast CT imaging data.

Disqualifiers

Non-diagnostic image quality;

Absence of a definitive reference-standard diagnosis;

Incomplete clinical or imaging data.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

100,000 Participants
are grouped into 3 trial groups

Sponsors and collaborators

Lian Yang

Lead sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Sponsor institution